Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antares Pharma, Inc.
Pharmaceutical company completes first phase of investor conferences
June 26th, 2004
Antares Pharma, Inc., (ANTR) announced that it completed the first phase of investor conferences during which invited guests were introduced to Antares Pharma and provided with a summary of publicly available information about the company and its business activities. Meetings were held in Chicago, Baltimore, Philadelphia, and Boston. During the meetings, Roger G. Harrison, PhD, Antares Pharma's CEO and president, highlighted the importance of patient compliance and emphasized that the company's technology platforms, including transdermal gels, fast-melt tablets, needle-free injectors and mini-needle injectors, are all intended to aid patients in...
Source: Law & Health Weekly (2004-06-26)
|
